These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1225 related articles for article (PubMed ID: 8161088)

  • 1. Evaluation of the prognostic significance of the site of origin of cutaneous melanoma.
    Law MM; Wong JH
    Am Surg; 1994 May; 60(5):362-6. PubMed ID: 8161088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BANS: a discussion of the problem.
    Bernengo MG; Reali UM; Doveil GC; Cappello N; Lisa F; Moretti S
    Melanoma Res; 1992 Sep; 2(3):157-62. PubMed ID: 1450669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B; Leiter U; Garbe C
    Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of anatomic site in prognosis in patients with cutaneous melanoma.
    Wong JH; Wanek L; Chang LJ; Goradia T; Morton DL
    Arch Surg; 1991 Apr; 126(4):486-9. PubMed ID: 2009064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison Among Clark's, Breslow's, and TNM classifications for cutaneous head and neck malignant melanoma.
    Morselli P; Masciotra L; Pinto V; Zollino I; Brunelli G; Carinci F
    J Craniofac Surg; 2007 Nov; 18(6):1353-8. PubMed ID: 17993881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
    Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
    J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis and staging in melanoma.
    Garrison M; Nathanson L
    Semin Oncol; 1996 Dec; 23(6):725-33. PubMed ID: 8970594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
    Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
    Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
    Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
    Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck cutaneous melanoma: a retrospective observational study on 146 patients.
    Koskivuo IO; Kinnunen IA; Suominen EA; Talve LA; Vihinen PP; Grénman RA
    Acta Oncol; 2009; 48(3):460-7. PubMed ID: 18843562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck.
    Austin JR; Byers RM; Brown WD; Wolf P
    Head Neck; 1996; 18(2):107-17. PubMed ID: 8647675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.
    Tas F; Keskin S; Karadeniz A; Dağoğlu N; Sen F; Kilic L; Yildiz I
    Oncology; 2011; 81(5-6):353-8. PubMed ID: 22248874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary surgical treatment of advanced-stage melanoma.
    Essner R; Lee JH; Wanek LA; Itakura H; Morton DL
    Arch Surg; 2004 Sep; 139(9):961-6; discussion 966-7. PubMed ID: 15381613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.